指南与共识妇科肿瘤

首届GCIG宫颈癌临床研究共识会议共识声明

Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.
指南 / 共识 · Lancet Oncol · 2026-01-01

The rigorous conduct of well designed clinical trials is critical to improving outcomes for patients with gynaecological cancers.…

要点

  • 33个GCIG成员组及多方代表参与制定16条宫颈癌临床研究共识声明
  • 共识覆盖诊断分期、早期、局部晚期及持续复发疾病四个专题
  • 所有声明均达成共识并汇总了未满足需求领域

核心结论

  • 首届GCIG宫颈癌临床研究共识会议成功制定并通过16条共识声明,覆盖诊断与分期、早期疾病、局部晚期疾病、持续或复发疾病四个专题,所有声明均达成共识。

主要发现

  • 会议在四个专题组内制定、完善并采纳了16条共识声明,所有声明均达成共识。
  • 会议识别并汇总了未满足需求领域。
  • 通过辩论、讨论和共识过程产生的高同意率体现了全球学术临床试验中对协调、包容和务实精神的积极承诺。

关键数值与推荐

  • 共识声明共16条,分布于诊断与分期、早期疾病、局部晚期疾病、持续或复发疾病四个专题组。
  • 所有33个GCIG成员组及额外代表参与了共识声明的制定、完善和采纳。

临床怎么用

  • 该共识声明可为肿瘤内科医生参与宫颈癌学术临床试验的设计要素、关键问题和未满足需求提供参考框架。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The rigorous conduct of well designed clinical trials is critical to improving outcomes for patients with gynaecological cancers. The Gynecologic Cancer InterGroup (GCIG) has promoted collaboration and harmonisation to guide clinical trials in ovarian and endometrial cancer through a series of consensus meetings with published statements. GCIG convened the inaugural Cervical Cancer Consensus Conference in Clinical Research in Dublin, Ireland, on Oct 14-15, 2024, to develop a consensus on design elements, essential questions, and unmet needs in cervical cancer research. All 33 GCIG member groups and additional representatives from patient advocates, young investigators, investigators from low-income and middle-income countries, and the Cervical Cancer Research Network participated in developing, refining, and adopting 16 statements within four topic groups: diagnosis and staging, early-stage disease, locally advanced disease, and persistent or recurrent disease. Consensus was obtained for all statements. Areas of unmet need were identified and tabulated. The high agreement rates generated through a process of debates, discussions, and consensus represent a positive commitment that incorporates harmonisation, inclusion, and pragmatism in the conduct of academic clinical trials globally.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Kataria B, Mukhopadhyay A, Oaknin A, et al. Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research. Lancet Oncol. 2026. PMID: 42508438. doi:10.1016/S1470-2045(26)00215-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。